| 000 | 01628 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250518063032.0 | ||
| 264 | 0 | _c20200316 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0223391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLi, Yuan | |
| 245 | 0 | 0 |
_aPenetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis. _h[electronic resource] |
| 260 |
_bPloS one _c2019 |
||
| 300 |
_ae0223391 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLinezolid _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPermeability |
| 650 | 0 | 4 | _aTandem Mass Spectrometry |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTissue Distribution |
| 650 | 0 | 4 |
_aTuberculosis, Multidrug-Resistant _xdrug therapy |
| 650 | 0 | 4 |
_aTuberculosis, Spinal _xdrug therapy |
| 700 | 1 | _aHuang, Hairong | |
| 700 | 1 | _aDong, Weijie | |
| 700 | 1 | _aLan, Tinglong | |
| 700 | 1 | _aFan, Jun | |
| 700 | 1 | _aWen, Shu'an | |
| 700 | 1 | _aZhang, Tingting | |
| 700 | 1 | _aQin, Shibing | |
| 700 | 1 | _aGuo, Ai | |
| 773 | 0 |
_tPloS one _gvol. 14 _gno. 10 _gp. e0223391 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0223391 _zAvailable from publisher's website |
| 999 |
_c30171051 _d30171051 |
||